Monopoly pricing with negative network effects: the case of vaccines
[Monopolpreisbildung mit negativen Netzwerkeffekten am Beispiel von Impfstoffen]
Author
Abstract
Suggested Citation
Download full text from publisher
Other versions of this item:
- Kessing, Sebastian G. & Nuscheler, Robert, 2006. "Monopoly pricing with negative network effects: The case of vaccines," European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
References listed on IDEAS
- Mason, Robin, 2000. "Network externalities and the Coase conjecture," European Economic Review, Elsevier, vol. 44(10), pages 1981-1992, December.
- Philipson, Tomas, 2000.
"Economic epidemiology and infectious diseases,"
Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799,
Elsevier.
- Tomas Philipson, 1999. "Economic Epidemiology and Infectious Diseases," NBER Working Papers 7037, National Bureau of Economic Research, Inc.
- Tomas Philipson & Stephane Mechoulan, 2003. "Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets," NBER Working Papers 9598, National Bureau of Economic Research, Inc.
- Geoffard, Pierre-Yves & Philipson, Tomas, 1997. "Disease Eradication: Private versus Public Vaccination," American Economic Review, American Economic Association, vol. 87(1), pages 222-230, March.
- Kessing, Sebastian G. & Nuscheler, Robert, 2006.
"Monopoly pricing with negative network effects: The case of vaccines,"
European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
- Kessing, Sebastian & Nuscheler, Robert, 2003. "Monopoly pricing with negative network effects: the case of vaccines [Monopolpreisbildung mit negativen Netzwerkeffekten am Beispiel von Impfstoffen]," Discussion Papers, Research Unit: Market Processes and Governance SP II 2003-06, WZB Berlin Social Science Center.
- Cabral, Luis M. B. & Salant, David J. & Woroch, Glenn A., 1999.
"Monopoly pricing with network externalities,"
International Journal of Industrial Organization, Elsevier, vol. 17(2), pages 199-214, February.
- Luis Cabral & David Salant & Glenn Woroch, 1994. "Monopoly Pricing With Network Externalities," Industrial Organization 9411003, University Library of Munich, Germany.
- Tomas Philipson, 1996. "Private Vaccination and Public Health: An Empirical Examination for U.S. Measles," Journal of Human Resources, University of Wisconsin Press, vol. 31(3), pages 611-630.
- Francis, Peter J., 1997. "Dynamic epidemiology and the market for vaccinations," Journal of Public Economics, Elsevier, vol. 63(3), pages 383-406, February.
- Bensaid, Bernard & Lesne, Jean-Philippe, 1996. "Dynamic monopoly pricing with network externalities," International Journal of Industrial Organization, Elsevier, vol. 14(6), pages 837-855, October.
- Michael Kremer, 2002. "Pharmaceuticals and the Developing World," Journal of Economic Perspectives, American Economic Association, vol. 16(4), pages 67-90, Fall.
- Brito, Dagobert L. & Sheshinski, Eytan & Intriligator, Michael D., 1991. "Externalities and compulsary vaccinations," Journal of Public Economics, Elsevier, vol. 45(1), pages 69-90, June.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Rikard Forslid & Mathias Herzing, 2015.
"On the Optimal Production Capacity for Influenza Vaccine,"
Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
- Forslid, Rikard & Herzing, Mathias, 2008. "On the Optimal Production Capacity for Influenza Vaccine," CEPR Discussion Papers 6808, C.E.P.R. Discussion Papers.
- Michael Kremer, Christopher M. Snyder & Christopher M. Snyder, 2013. "When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity - Working Paper 334," Working Papers 334, Center for Global Development.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2022.
"Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses,"
Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," NBER Working Papers 27757, National Bureau of Economic Research, Inc.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Working Papers 2020-17, The George Washington University, Institute for International Economic Policy.
- Bloom, David & Kuhn, Michael & Prettner, Klaus, 2021. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," CEPR Discussion Papers 15997, C.E.P.R. Discussion Papers.
- Bloom, David E. & Kuhn, Michael & Prettner, Klaus, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," IZA Discussion Papers 13625, Institute of Labor Economics (IZA).
- Michael Kremer & Christopher M. Snyder, 2015.
"Preventives Versus Treatments,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(3), pages 1167-1239.
- Michael Kremer & Christopher Snyder, 2015. "Preventives Versus Treatments," NBER Working Papers 21012, National Bureau of Economic Research, Inc.
- Nicolas Houy, 2013.
"Are better vaccines really better? The case of a simple stochastic epidemic SIR model,"
Economics Bulletin, AccessEcon, vol. 33(1), pages 207-216.
- Nicolas Houy, 2013. "Are better vaccines really better? The case of a simple stochastic epidemic SIR model," Post-Print halshs-00927441, HAL.
- Michael Kremer & Christopher Snyder, 2013.
"When is Prevention More Profitable than Cure?,"
CID Working Papers
252, Center for International Development at Harvard University.
- Michael Kremer & Christopher Snyder, 2013. "When is Prevention More Profitable than Cure?," Growth Lab Working Papers 46, Harvard's Growth Lab.
- Kessing, Sebastian G. & Nuscheler, Robert, 2006.
"Monopoly pricing with negative network effects: The case of vaccines,"
European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
- Kessing, Sebastian & Nuscheler, Robert, 2003. "Monopoly pricing with negative network effects: the case of vaccines [Monopolpreisbildung mit negativen Netzwerkeffekten am Beispiel von Impfstoffen]," Discussion Papers, Research Unit: Market Processes and Governance SP II 2003-06, WZB Berlin Social Science Center.
- Isabel Helmrath & Matthias Hunold & Johannes Muthers, 2022. "Joint procurement by heterogeneous buyers," Economics working papers 2022-14, Department of Economics, Johannes Kepler University Linz, Austria.
- Alexander E. Saak & David A. Hennessy, 2018.
"A model of reporting and controlling outbreaks by public health agencies,"
Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 66(1), pages 21-64, July.
- Saak, Alexander E. & Hennessy, David A., 2016. "A model of reporting and controlling outbreaks by public health agencies:," IFPRI discussion papers 1529, International Food Policy Research Institute (IFPRI).
- Herrmann, Markus, 2010.
"Monopoly pricing of an antibiotic subject to bacterial resistance,"
Journal of Health Economics, Elsevier, vol. 29(1), pages 137-150, January.
- Markus Herrmann, 2009. "Monopoly Pricing of an Antibiotic Subject to Bacterial Resistance," Cahiers de recherche 0946, CIRPEE.
- Stéphane Mechoulan, 2007.
"Market structure and communicable diseases,"
Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics, Canadian Economics Association, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2005. "Market Structure and Communicable Diseases," Working Papers tecipa-241, University of Toronto, Department of Economics.
- Proano, Ruben A. & Jacobson, Sheldon H. & Zhang, Wenbo, 2012. "Making combination vaccines more accessible to low-income countries: The antigen bundle pricing problem," Omega, Elsevier, vol. 40(1), pages 53-64, January.
- Pekka S��skilahti, 2015.
"Monopoly Pricing of Social Goods,"
International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(3), pages 429-448, November.
- Sääskilahti, Pekka, 2007. "Monopoly pricing of social goods," MPRA Paper 3526, University Library of Munich, Germany.
- Sumana Kundu & Rupayan Pal, 2024. "Individuals social concern, externalities and voluntary vaccination: Monopoly and first-best public policy," Indira Gandhi Institute of Development Research, Mumbai Working Papers 2024-023, Indira Gandhi Institute of Development Research, Mumbai, India.
- Amir, Rabah & Liu, Zhiwei & Tian, Jingwen, 2023. "Negative network effects and public policy in vaccine markets," Journal of Economic Behavior & Organization, Elsevier, vol. 216(C), pages 136-149.
- Michael Kremer & Christopher M. Snyder, 2013.
"When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity,"
Working Paper
70726, Harvard University OpenScholar.
- Michael Kremer & Christopher M. Snyder, 2013. "When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity," NBER Working Papers 18862, National Bureau of Economic Research, Inc.
- Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(2), pages 121-134, June.
- Kremer, Michael & Snyder, Christopher, 2015. "Vaccines vs. Preventives," CEPR Discussion Papers 10474, C.E.P.R. Discussion Papers.
- Terrence August & Tunay I. Tunca, 2006. "Network Software Security and User Incentives," Management Science, INFORMS, vol. 52(11), pages 1703-1720, November.
- Xu, Danni & Wang, Fan & Zhuo, Xiaopo & Liu, Yaoqi, 2024. "The performance of government subsidy schemes in a competitive vaccine market considering consumers' free-riding behavior," International Journal of Production Economics, Elsevier, vol. 268(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Rikard Forslid & Mathias Herzing, 2015.
"On the Optimal Production Capacity for Influenza Vaccine,"
Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
- Forslid, Rikard & Herzing, Mathias, 2008. "On the Optimal Production Capacity for Influenza Vaccine," CEPR Discussion Papers 6808, C.E.P.R. Discussion Papers.
- Stéphane Mechoulan, 2007.
"Market structure and communicable diseases,"
Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics, Canadian Economics Association, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2005. "Market Structure and Communicable Diseases," Working Papers tecipa-241, University of Toronto, Department of Economics.
- Troy Tassier & Philip Polgreen & Alberto Segre, 2015. "Vaccination Games with Peer Effects in a Heterogeneous Hospital Worker Population," Administrative Sciences, MDPI, vol. 5(1), pages 1-25, January.
- Xinyan Shi, 2013. "Information disclosure and vaccination externalities," International Journal of Economic Theory, The International Society for Economic Theory, vol. 9(3), pages 229-243, September.
- Proano, Ruben A. & Jacobson, Sheldon H. & Zhang, Wenbo, 2012. "Making combination vaccines more accessible to low-income countries: The antigen bundle pricing problem," Omega, Elsevier, vol. 40(1), pages 53-64, January.
- Pekka S��skilahti, 2015.
"Monopoly Pricing of Social Goods,"
International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(3), pages 429-448, November.
- Sääskilahti, Pekka, 2007. "Monopoly pricing of social goods," MPRA Paper 3526, University Library of Munich, Germany.
- Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(2), pages 121-134, June.
- Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
- Mark Gersovitz & Jeffrey S. Hammer, 2004.
"The Economical Control of Infectious Diseases,"
Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.
- Gersovitz, Mark & Hammer, Jeffrey S., 2001. "The economic control of infectious diseases," Policy Research Working Paper Series 2607, The World Bank.
- Paulo Maçãs Nunes, 2015. "Pricing Strategy In The Context Of Durable Goods Monopoly With Discrete Demand," Economic Annals, Faculty of Economics and Business, University of Belgrade, vol. 60(204), pages 61-74, January –.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2022.
"Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses,"
Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," NBER Working Papers 27757, National Bureau of Economic Research, Inc.
- Bloom, David & Kuhn, Michael & Prettner, Klaus, 2021. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," CEPR Discussion Papers 15997, C.E.P.R. Discussion Papers.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Working Papers 2020-17, The George Washington University, Institute for International Economic Policy.
- Bloom, David E. & Kuhn, Michael & Prettner, Klaus, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," IZA Discussion Papers 13625, Institute of Labor Economics (IZA).
- Terrence August & Tunay I. Tunca, 2006. "Network Software Security and User Incentives," Management Science, INFORMS, vol. 52(11), pages 1703-1720, November.
- Barrett, Scott & Hoel, Michael, 2007.
"Optimal disease eradication,"
Environment and Development Economics, Cambridge University Press, vol. 12(5), pages 627-652, October.
- Michael Hoel & Scott Barrett, 2004. "Optimal Disease Eradication," Working Papers 2004.50, Fondazione Eni Enrico Mattei.
- Barrett, Scott & Hoel, Michael, 2009. "Optimal Disease Eradication," HERO Online Working Paper Series 2003:23, University of Oslo, Health Economics Research Programme.
- Corey White, 2021.
"Measuring Social and Externality Benefits of Influenza Vaccination,"
Journal of Human Resources, University of Wisconsin Press, vol. 56(3), pages 749-785.
- Corey White, 2018. "Measuring the Social and Externality Benefits of Influenza Vaccination," Working Papers 1803, California Polytechnic State University, Department of Economics.
- White, Corey, 2019. "Measuring Social and Externality Benefits of in Influenza Vaccination," IZA Discussion Papers 12525, Institute of Labor Economics (IZA).
- Ngo Long, 2015. "Dynamic Games Between Firms and Infinitely Lived Consumers: A Review of the Literature," Dynamic Games and Applications, Springer, vol. 5(4), pages 467-492, December.
- Philipson, Tomas, 2000.
"Economic epidemiology and infectious diseases,"
Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799,
Elsevier.
- Tomas Philipson, 1999. "Economic Epidemiology and Infectious Diseases," NBER Working Papers 7037, National Bureau of Economic Research, Inc.
- Sabine Liebenehm & Bernard Bett & Cristobal Verdugo & Mohamed Said, 2016. "Optimal Drug Control under Risk of Drug Resistance – The Case of African Animal Trypanosomosis," Journal of Agricultural Economics, Wiley Blackwell, vol. 67(2), pages 510-533, June.
- Laussel, Didier & Van Long, Ngo & Resende, Joana, 2015.
"Network effects, aftermarkets and the Coase conjecture: A dynamic Markovian approach,"
International Journal of Industrial Organization, Elsevier, vol. 41(C), pages 84-96.
- Didier LAUSSEL & Ngo Van LONG & Joana RESENDE, 2014. "Network Effects, Aftermarkets and the Coase Conjecture : A Dynamic Markovian Approach," Cahiers de recherche 06-2014, Centre interuniversitaire de recherche en économie quantitative, CIREQ.
- Didier Laussel & Ngo van Long & Joana Resende, 2015. "Network effects, aftermarkets and the Coase conjecture: A dynamic Markovian approach," Post-Print hal-01457339, HAL.
- Cerquera Dussán, Daniel, 2007. "Durable Goods, Innovation and Network Externalities," ZEW Discussion Papers 07-086, ZEW - Leibniz Centre for European Economic Research.
- Michael Kremer & Christopher M. Snyder, 2015.
"Preventives Versus Treatments,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(3), pages 1167-1239.
- Michael Kremer & Christopher Snyder, 2015. "Preventives Versus Treatments," NBER Working Papers 21012, National Bureau of Economic Research, Inc.
More about this item
Keywords
Vaccination; monopoly pricing; price discrimination; negative network effects; Pigouvian subsidies; mandatory vaccination programs;All these keywords.
JEL classification:
- D42 - Microeconomics - - Market Structure, Pricing, and Design - - - Monopoly
- D62 - Microeconomics - - Welfare Economics - - - Externalities
- H23 - Public Economics - - Taxation, Subsidies, and Revenue - - - Externalities; Redistributive Effects; Environmental Taxes and Subsidies
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:wzbmpg:spii200306. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/mpswzde.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.